Morgan Keegan has a Market Perform rating and a $4 price target on shares of Alliance HealthCare Services AIQ.
In a note to clients, Morgan Keegan writes, "Our adjusted EBITDA estimate is $35.0 million, a 8.5% decline from the prior year period. We consider this a better indicator of profitability than EPS due to the high amounts of noncash depreciation and amortization. Our EPS estimate of ($0.07) is $0.01 below the First Call consensus. We expect Alliance's business continued to be affected by weak demand for healthcare services during the fourth quarter."
Shares of AIQ lost 3 cents yesterday to close at $4.06, a loss of 0.73%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.